Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
Condition(s):COVID-19; Corona Virus InfectionLast Updated:April 27, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19; Corona Virus InfectionLast Updated:April 27, 2023Recruiting
Condition(s):Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE; Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM); Pediatric-Onset Multiple Sclerosis (POMS)Last Updated:March 26, 2024Active, not recruiting
Condition(s):COVID-19; Vaccine Reaction; Immunization; InfectionLast Updated:February 9, 2023Completed
Condition(s):Hepatitis B; HealthyLast Updated:July 25, 2022Completed
Condition(s):Breast Cancer Related Lymphedema; Covid19Last Updated:December 28, 2023Active, not recruiting
Condition(s):Influenza; COVID-19Last Updated:February 7, 2024Recruiting
Condition(s):COVID-19Last Updated:March 15, 2024Withdrawn
Condition(s):COVID-19 VaccinesLast Updated:July 3, 2023Active, not recruiting
Condition(s):Anaphylactic Reaction; Vaccine ReactionLast Updated:October 20, 2021Unknown status
Condition(s):Vaccine Reaction; COVID-19; Children, OnlyLast Updated:April 29, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.